Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors), PIM1 inhibitors(Proto-oncogene serine/threonine-protein kinase Pim-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | KR | 01 Mar 2023 | |
Rheumatoid Arthritis | Preclinical | KR | 01 Mar 2023 |